Meiting Chen

9PUBLICATIONS
22CO-AUTHORS
ChemotherapyClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 07, 2025
Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial.

Qi-Xiang Rong, Mei-Ting Chen, Wei Yang

|Jul 01, 2025
Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study.

Cong Xue, Qianyi Liao, Riqing Huang

|Apr 08, 2025
Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial.

Meiting Chen, Riqing Huang, Qixiang Rong

|Mar 10, 2025
PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study.

Riqing Huang, Haifeng Li, Shuo Li

|Jan 02, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.

Ruo-Xi Hong, Fei Xu, Wen Xia

|Mar 22, 2024
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.

Meiting Chen, Lu Li, Qing Xia

Pageof 2

Frequent Collaborators

5 joint publications

Yanxia Shi

3 joint publications

Cong Xue

2 joint publications

Zhongyu Yuan

2 joint publications

Xin An